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ARTICLE
Exclusive breastfeeding protects against 
postpartum migraine recurrence attacks?
O aleitamento materno exclusivo protege contra a recorrência de  
crises de enxaqueca no pós-parto?
Waldmiro Antônio Diégues Serva1, Vilneide Maria Santos Braga Diégues Serva2, Maria de Fátima Costa 
Caminha3, José Natal Figueiroa4, Gabriel Braga Diégues Serva5, Marcelo Moraes Valença6
Migraine, mainly without aura, is influenced by cyclical 
hormones changes that occur during the women’s reproduc-
tive life1-4. It is predominantly during the menstrual period 
that attacks occur and, in some cases, exclusively5. The most 
accepted hypothesis for the physiopathology of attacks dur-
ing menstruation lies in the sharp decrease of estrogens dur-
ing the premenstrual period1,5,6. 
However, the majority of the pregnant women that are 
migraine sufferers before pregnancy show migraine improve-
ment or even disappearance during pregnancy7,8. Absence of 
cyclical hormonal fluctuations during pregnancy, mainly es-
trogens that rise during this period, is pointed as one of the 
most important causes of such behavior4,8.
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AbsTRACT
Objectives: To observe postpartum migraine recurrence among migraine sufferers before pregnancy, its classifications and associated 
factors and to compare women, who were exclusively breastfeeding, with those that used other forms of infant feeding. Methods: Out 
of 686 consecutively assisted women, at the first postnatal week, 266 were identified as migraine sufferers before pregnancy. Among 
those, one in five that were exclusively breastfeeding (53) and all the ones consecutively using others forms of infant feeding (40) were 
interviewed at the first and forth postpartum weeks. Results: After multivariable analysis, exclusive breastfeeding, no breastfeeding 
problems, and low income were associated with decrease in migraine recurrence at the first postpartum week. At the fourth week, exclu-
sive breastfeeding continued to be a protective factor. Conclusions: A decrease in postpartum migraine recurrence seems to be another 
advantage of exclusive breastfeeding.
Key words: migraine without aura, migraine with aura, breast feeding, postpartum period.
REsumo
Objetivos: Observar a recorrência de enxaqueca no período pós-parto em mulheres com enxaqueca antes da gestação, suas classificações e 
fatores associados e comparar mulheres que apenas amamentavam com aquelas que alimentavam seus filhos de outro modo. Métodos: De 
686 mulheres consecutivamente assistidas na primeira semana pós-parto, 266 foram identificadas como portadoras de enxaqueca antes 
da gestação. Destas, uma em cada cinco que se encontravam amamentando exclusivamente (53) e aquelas que usavam outras modalidades 
de alimentação (40) foram entrevistadas na primeira e quarta semanas pós-parto. Resultados: Após análise multivariada, observou-se que 
praticar aleitamento materno exclusivo, não ter problemas relacionados à amamentação e ter baixa renda estavam associados à diminui-
ção da recorrência da enxaqueca na primeira semana pós-parto. Na quarta semana, a prática do aleitamento materno exclusivo continuou 
sendo fator protetor em relação à enxaqueca. Conclusões: A diminuição da recorrência da enxaqueca pós-parto parece ser uma vantagem 
adicional do aleitamento materno exclusivo.
Palavras-Chave: enxaqueca sem aura, enxaqueca com aura, aleitamento materno, período pós-parto. 
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The protective effect of the gestational period ceases rap-
idly in the postpartum period and migraine returns to its 
normal course7. However, a protective association between 
breastfeeding and migraine recurrence in the postnatal pe-
riod was previously observed7.
There are countless benefits attributed to breastfeeding, 
not only for the woman9,10, but for the child, and, particularly 
when exclusive breastfeeding is used10-12. One must refer not 
only the nutritional aspects of breastfeeding, but the preven-
tion of deficiencies, diseases, and death10-12. It is also neces-
sary to cite breastfeeding as a program agent with potential 
long-term biological effect for the structure and function of 
the organism13,14. These are some of the reasons why breast-
feeding practice has been internationally recommended15. 
The objective of the present study was to observe migraine 
recurrence in the first postpartum week and to follow it up 
prospectively in the fourth week after delivery among ante-
natal migraine sufferers, comparing this recurrence between 
women that were exclusively breastfeeding with those that 
used other forms of infant feeding (OFI). 
mETHoDs
This is a follow-up study with two components, retro-
spective and prospective, undertaken at the Breast Milk 
Bank (BMB) of the Instituto de Medicina Integral Professor 
Fernando Figueira (IMIP) in Recife, Brazil, from June to 
November, in 2009.
The sample was calculated taking into account informa-
tion from a study by Sances et al.7. In this study, the recur-
rence of the migraine attacks in the first postpartum week 
was 21.6% (95%CI 9.8–38.2), among women who breastfeed 
exclusively, and 80.0% (95%CI 44.4–97.0%), among those 
who used infant formula. In the first postpartum month, 
these percentages were, respectively, 43.2 (95%CI 27.1–60.5) 
and 100.0% (95%CI 74.0–100.0). Given that the accuracy of 
these estimates can only be considered reasonable, as in-
dicated by their respective confidence intervals, we opted 
for a more cautious alternative about the possible differ-
ences between migraine recurrence in both groups, exclu-
sive breastfeeding (EBF), defined as when the infant is fed 
exclusively breast milk, except for minerals and vitamins 
prescribed by a physician and OFI16. Regarding the OFI, it 
has been included women who were predominantly breast-
feeding, using total breastfeeding (use of breast milk and 
also other food or drink) or bottle feeding16. Therefore, it 
was chosen an expected difference of 70.0% for the group 
of women who adopted OFI and 30.0% for those who were 
EBF, in order to identify a difference in migraine recurrence 
between the two groups of 40.0%. Thus, it was considered 
that a sample of 80 participants (40 for each group of in-
fant feeding) would be enough to identify factors associated 
with migraine recurrence, both in the first and fourth post-
partum weeks. 
After signing the informed consent form, at the end of 
the first postpartum week, a questionnaire was applied to 
all women that attended the first postnatal visit at the BMB 
and that had given birth at the Institution. The question-
naire included questions related to some socioeconomic 
(years of schooling, per capita income, age, race/color of the 
skin, marital status, and occupation), obstetric (number 
of pregnancies, diseases during pregnancy, type of deliv-
ery, and of feeding offered to newborns and breastfeeding 
problems), and biological factors (with or without aura mi-
graine during pregnancy, with or without aura related to 
menstruation migraine before pregnancy, presence of ten-
sion-type headache (TTH) associated with migraine with 
or without aura before pregnancy and with or without 
aura migraine recurrence in the first and fourth postpar-
tum weeks). There were also questions about headache 
classification before pregnancy and in the first and fourth 
postpartum weeks17.
Women affected by migraine with aura (MA), as well as 
those affected by migraine without aura (MO) before preg-
nancy, who were related or not to menstruation and classi-
fied according to the International Classification of Headache 
Disorders (ICHD)17, were included in the study group. Those 
with contraindication to breastfeed, who did not want to par-
ticipate in the research project, unable to be contacted for 
the follow-up interview in the fourth postpartum week and 
who had neurological diseases that characterized secondary 
headache were not included in the sample. Postdural punc-
ture headaches, in cesarean section cases, were excluded, an-
alyzing the clinical characteristics of the headache. Epidural 
anesthesia was not used for vaginal deliveries.
Although the definition of pure menstrual migraine and 
migraine related to menstruation refers to MO17, due to the 
difficulty in identifying retrospectively migraine that oc-
curs only during the menstrual period and distinguishing it 
of those that occur both during and outside the menstrual 
period18, we grouped these two categories and called them 
menstrually-related migraine. This nomenclature was used 
in both MO and MA cases (when MA sufferers referred mi-
graine attacks related to the menstrual period or not in it).
The first interview was intended to select the sample. Out 
of all the identified MO and MA sufferers, it was decided to 
interview one woman in every five, who was using exclusive-
ly breastfeeding as a feeding method in the first postpartum 
week and was a migraine suffer prior to pregnancy, because, 
according to the BMB of the IMIP records, the prevalence of 
EBF at the end of the first postpartum week was of 83.0%. 
While for the OFI Group, all the women consecutively at-
tending the BMB/IMIP that were not exclusively breastfeed-
ing were interviewed, until it was reached 40 women of the 
sample size calculation.
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In the fourth postpartum week, the second part of the 
questionnaire was applied, investigating again the type of in-
fant feeding, migraine recurrence, and its classification17. 
To compare the type of infant feeding offered by the 
women, EBF or OFI, with migraine recurrence in the first and 
fourth postpartum weeks, the χ2 was used. 
Based on the literature7, independent variables that con-
stituted risk or protection factors for migraine recurrence 
in the first and fourth postpartum weeks were selected. 
Socioeconomic and demographic factors formed the first 
block of variables (maternal education, per capita income, ma-
ternal age, race/color of the skin, marital status, and mater-
nal occupation). The second block included variables related 
to obstetric factors and type of infant feeding (number of preg-
nancies, diseases during pregnancy, type of delivery, type of 
feeding offered to newborns, and breastfeeding problems). The 
third block included biological factors related to migraine.
The outcome was represented by migraine recurrence in 
the first and fourth postpartum weeks.
The bivariate analysis allowed identifying the explanatory 
variables considering as screening criteria the associations 
with p<0.20. The statistical significance of each variable was 
calculated using the Wald test for heterogeneity. Then, a mul-
tivariate analysis using Poisson’s multiple regression with ro-
bust standard error was performed, the adjusted prevalence 
ratios, their respective 95% confidence intervals, and their 
statistical significances were estimated, adopting p<0.05, us-
ing the same tests described before. The χ2 was used to com-
pare the type of infant feeding with migraine recurrence in 
the first and fourth postpartum weeks. Stata 9.2 SE was used 
to analyze data.
The research project, under the number 1389, was ap-
proved by the Ethics Committee for Research in Human 
Beings of IMIP, in an Ordinary Meeting on April 16th, 2009.
REsuLTs
During the six months of the sample selection, 686 wom-
en were assisted at the BMB/IMIP for the first postnatal vis-
it. Of these, 266 (38.8%) were identified as MO or MA suffer-
ers before pregnancy. Of the 266 women, 98 were selected 
as a sub-sample for the current study, with 5 exclusions (in 
the EBF Group) due to the impossibility of locating them 
for the follow-up interview in the fourth postpartum week. 
Therefore, the final sample was composed of 93 women, 53 
were EBF their newborns and 40 were using OFI.
Among the 93 women and according to the ICHD17, there 
were 82 (88.2%), 27 (29.0%) and 44 (47.3%) MO sufferers, re-
spectively, before pregnancy and in the first and fourth post-
partum weeks. In relation to MA, there were 11 (11.8%), 6 
(6.5%) and 7 (7.5%) sufferers, respectively, before pregnancy 
and in the first and fourth postpartum weeks.
The women’s mean age was 27 years-old, with a standard 
deviation of 6.6 years. Most of them reported themselves as 
black/colored (68.0%), were married or had a consensual 
union (82.8%), did not work (58.0%), had finished High School 
(71.0%) and were poor, with a per capita income bellow half of 
the minimum national wage (80.6%). Most of the women were 
primigravid (63.4%). Twenty-nine (31.2%) had diseases during 
pregnancy. Of these, eight (8.6%) had high-blood pressure, sev-
en (7.5%) had diabetes and six (6.5%) had urinary tract infec-
tions. Most of them had vaginal deliveries (63.4%).
None of the women experiencing migraine remission 
during the first and second trimesters of pregnancy showed 
migraine attacks in the third trimester. Only ten women con-
tinued to have migraine attacks during all their gestation pe-
riod. Migraine returned after delivery in 9 (9.7%) women in 
the first 48 hours, in 33 (35.5%) and in 51 (54.8%) women, re-
spectively, in the first and fourth postpartum weeks.
In relation to the association between type of infant feed-
ing and migraine recurrence, both in the first and fourth post-
partum weeks, there was a statistically significant difference 
(p<0.001) among migraine sufferers prior to pregnancy, when 
women that exclusively breastfed were compared to those 
that used OFI (Table 1).
Tables 2 and 3 present the results of the crude and ad-
justed prevalence ratios (PR), which were calculated with 
Poisson’s multiple regression analysis for the associated fac-
tors to migraine recurrence, respectively, in the first and 
fourth postnatal weeks. 
After bivariate analysis, per capita income, disease during 
pregnancy, type of infant feeding and breastfeeding problems 
showed a statistically significant association with migraine 
recurrence in the first postpartum week. After multivariate 
analysis, in the final model, only per capita income, type of 
infant feeding, and breastfeeding problems remained statisti-
cally significant (Table 2).
Table 3 shows that, after the bivariate analysis, years of 
schooling, type of infant feeding and breastfeeding problems 
showed a statistically significant association with migraine 
recurrence in the fourth postpartum week, but after Poisson’s 
multiple regression analysis only EBF maintained a signifi-
cant association.
Table 1. Type of infant feeding and migraine recurrence in the 
first and fourth postpartum weeks among 93 with and without 
aura migraine sufferers before pregnancy.
Type of infant
feeding
Migraine recurrence 
in the 1st
postpartum week
Migraine recurrence 
in the 4th
postpartum week
Exclusive
breastfeeding,
n/total (%)
4/53 (7.5)* 17/53 (32.1)**
Other forms of
infant feeding,
n/total (%)
29/40 (72.5)* 34/40 (85.0)**
* χ2; **p<0.001.
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Table 2. Crude and adjusted prevalence ratios (PR), with 95% confidence interval (95%CI), according to socioeconomic and 
demographic, obstetric, related to breastfeeding and biological factors for migraine recurrence in the first postpartum week 
among 93 with and without aura migraine sufferers.
Independent variables
Migraine 
recurrence
n/total (%)
Crude PR 95%CI p-value* Adjusted PR 95%CI p-value*
Years of schooling
1st to 8th
9 or more
6/20 (30.0)
27/73 (37.0)
0.8
1
0.4–1.7
0.563
– –
–
Per capita income (minimum wage)
<0.5
≥0.5
22/75 (29.3)
11/18 (61.1)
0.5
1
0.3–0.8 0.011 0.5
1
0.3–0.9 0.020
Maternal age
<27 years-old
27 and + years-old
15/47 (31.9)
18/46 (39.1)
0.8
1
0.5–1.4
0.467
– –
–
Race/skin color
White
Black/colored
9/29 (31.0)
24/64 (37.5)
0.8
1
0.4–1.6
0.546
– –
–
Marital status
Married
Single
29/77 (37.7)
4/16 (25.0)
1.5
1
0.6–3.7
0.335
– –
–
Occupation
Do not work
Work/s tudy
16/54 (29.6)
17/39 (43.6)
0.7
1
0.4–1.2
0.165
0.8
1
0.5–1.5
0.503
Number of pregnancies
1
>1
25/59 (42.4)
8/34 (23.5)
1.8
1
0.9–3.5
0.067
0.7
1
0.4–1.2
0.211
Disease during pregnancy
Yes
No
16/29 (55.2)
17/64 (26.6)
2.1
1
1.2–3.5 0.008 1.3
1
0.9–2.0 0.138
Type of delivery
Normal
Cesarean
18/59 (30.5)
15/34 (44.1)
0.7
1
0.4–1.2
0.186
1.1
1
0.7–1.6
0.645
Type of infant feeding
Exclusive breastfeeding
Other forms of feeding
4/53 (7.5)
29/40 (72.5)
0.1
1
0.0–0.3 <0.001 0.1
1
0.05–0.40 <0.001
Breastfeeding problems
Yes
No
23/45 (51.1)
10/48 (20.8)
2.5
1
1.3–4.6 0.002 1.8
1
1.1–3.0 0.025
Menstrually related MO before pregnancy
Yes
No
19/47 (40.4)
14/46 (30.4)
1.3
1
0.8–2.3 0.314 – – –
Menstrually related  MA before pregnancy
Yes
No
4/7 (57.1)
29/86 (33.7)
1.7
1
0.8–3.4 0.213 – – –
TTH before pregnancy
Yes
No
4/12 (33.3)
29/81 (35.8)
0.9
1
0.4–2.2 0.868 – – –
Migraine during pregnancy
Yes
No
25/64 (39.1)
8/29 (27.6)
1.4
1
0.7–2.8 0.284 – – –
Migraine in the 3rd trimester of pregnancy
Yes
No
5/10 (50.0)
28/83 (33.7)
1.5
1
0.7–3.0 0.310 – – –
*Wald test for heterogeneity; variables highlighted in black were included in the multivariate analysis.
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Table 3. Crude and adjusted prevalence ratios (PR), with 95% confidence interval (95% CI), according to socioeconomic and 
demographic; obstetric and related to breastfeeding, and biological factors for migraine recurrence in the fourth postpartum 
week among 93 with and without aura migraine sufferers.
*Wald test for heterogeneity; variables highlighted in black were included in the multivariate analysis.
Independent variables
Migraine 
recurrence
n/Total (%)
Crude
PR
95%CI p-value*
Adjusted
PR
95%CI p-value*
Years of schooling
1st to 8th
9 ou more
7/20 (35.0)
44/73 (60.3)
0.6
1
0.3–1.1 0.044 0.7
1
0.4–1.2 0.186
Per capita income (minimum wage)
<0.5
≥0.5
38/75 (50.7)
13/18 (72.2)
0.7
1
0.5–1.0 0.099 0.9
1
0.7–1.2 0.578
Maternal age
<27 years-old
27 and + years-old
25/47 (53.2)
26/46 (56.5)
0.9
1
0.7–1.4 0.747 – – –
Race/skin color
White
Black/colored
16/29 (55.2)
35/64 (54.7)
1.0
1
0.7–1.5
0.965
– –
–
Marital status
Married
Single
45/77 (58.4)
6/16 (37.5)
1.6
1
0.8–3.0
0.126
1.6
1
0.9–2.8
0.138
Occupation
Do not work
Work/study
27/54 (50.0)
24/39 (61.5)
0.8
1
0.6–1.2
0.270
– –
–
Number of pregnancies
1
>1
35/59 (59.3)
16/34 (47.1)
1.3
1
0.8–1.9 0.252 – –
–
Disease during pregnancy
Yes
No
20/29 (69.0)
31/64 (48.4)
1.4
1
1.0–2.0 0.065 1.1
1
0.8–1.5 0.435
Type of delivery
Normal
Cesarean
28/59 (47.5)
23/34 (67.9)
0.7
1
0.5–1.0
0.059
1.0
1
0.7–1.4
0.962
Type of infant feeding
Exclusive breastfeeding
Other forms of feeding
17/53 (32.1)
34/40 (85.0)
0.4
1
0.3–0.6 <0.001 0.4
1
0.3–0.6 <0.001
Breastfeeding problems at the 1st postpartum week
Yes
No
31/45 (68.9)
20/48 (41.7)
1.7
1
1.1–2.4 0.008 1.3
1
0.9–1.8 0.116
Breastfeeding problems at the 4th postpartum week
Yes
No
9/15 (60.0)
42/78 (53.8)
1.1
1
0.7–1.8 0.661 – – –
Menstrually related MO before pregnancy
Yes
No
29/47 (61.7)
22/46 (47.8)
1.3
1
0.9–1.9 0.179 1.2
1
0.9–1.7 0.265
Menstrually related MA before pregnancy
Yes
No
3/7 (42.9)
48/86 (55.8)
0.8
1
0.3–1.8 0.508 – – –
TTH before pregnancy
Yes
No
8/12 (66.7)
43/81 (53.1)
1.3
1
0.8–2.0 0.378 – – –
Migraine during pregnancy
Yes
No
39/64 (60.9)
12/29 (41.4)
1.5
1
0.9–2.4 0.079 1.4
1
0.9–2.1 0.058
Migraine in the 3rd trimester of pregnancy
Yes
No
6/10(60.0)
45/83(54.2)
1.1
1
0.6–1.9 0.728 – – –
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DIsCussIoN
Migraine attacks return quickly in the postpartum period, 
after a decline or even disappearance during pregnancy1,7,19. 
Sances et al.7, studying only MO individuals, have demon-
strated that 34.0 and 55.3% of women had MO recurrence, 
respectively, in the first and fourth postpartum weeks. The 
present study showed similar recurrence rates, 35.5 and 
55.9%, respectively, at the end of the first and fourth postna-
tal weeks, in both MO and MA sufferers. 
Pregnancy and EBF suppress ovulation and the menstrual 
cycle, and, the hormonal changes involved affect the frequen-
cy of migraine attacks in the majority of the women, even in 
those with no history of menstrual migraine1,7. During preg-
nancy, the corpus luteum and later the placenta and fetal adre-
nal tissues secrete increasing quantities of estrogen1,20. These 
increasing estrogen levels are attributed as one of the reasons 
why there is a decline in migraine attacks1,20. However, with-
in the first hour after delivery, estrogen levels fall by around 
80.0% and similar ones encountered in the follicular stage of 
the menstrual cycle are found approximately 35 hours after 
delivery21. Early migraine attacks are probably triggered by 
this abrupt fall in estrogen levels1,7. After multivariate analy-
sis, the present study showed that the absence of EBF in the 
first postpartum week is a risk factor for migraine recurrence 
among migraine sufferers before pregnancy. Increased lev-
els of hormones and antinociceptive neurotransmitters dur-
ing breastfeeding period may be part of the explanation of 
the difference found in migraine recurrence after delivery22,23. 
Oxytocin, for example, reduces the behavioral and neuroen-
docrine responses to stress and together with vasopressin 
are key mediators of the complex social behavior, including 
attachment and social recognition24. Thus, psychological re-
percussion of the interruption of EBF25 can contribute as a 
possible associated factor with migraine recurrence in the 
postnatal period7. 
Hormonal fluctuations due to the return of ovulation oc-
cur approximately in 3, 6, and 27 weeks after delivery, respec-
tively, in cases of lactation suppression, nonbreastfeeding, 
and EBF26. This may be one of the explanations for the protec-
tion of EBF found in both bivariate and multivariate analysis, 
in relation to the recurrence of migraine attacks in both MO 
and MA sufferers, in the fourth postpartum week.
The recurrence of migraine attacks, in the first and fourth 
postpartum weeks, among menstrually related MO and MA 
sufferers, was not statistically significant in the present study, 
probably due to the definition used for menstrually related 
migraine, which included both pure menstrual migraine and 
that related to menstruation in MO and MA sufferers. 
In addition to the menstrual cycle hormones, endogenous 
opioids, serotonin and adrenergic central system of many 
pure menstrual migraine or menstrually related migraine 
sufferers may be altered in the premenstrual syndrome3,27. 
Therefore, studies are needed to investigate the pattern of 
these hormones during the lactation period and their associ-
ation with the reduction of migraine recurrence during post-
partum. The presence of beta-endorphin, for example, may 
be one explanation for the present findings, especially in the 
first week after delivery, when endogenous opioids levels are 
greater in the woman and consequently in breast milk28. 
Breastfeeding problems are associated with early 
weaning25,29. Probably this was the reason why there was 
a statistically significant difference in both bivariate and 
Poisson’s multiple regression analysis, for migraine recur-
rence in the first week after delivery. In the fourth week, this 
variable was considered for the multivariate analysis, but it 
was not significant.
In the first postpartum week, the higher the income, the 
greater was the risk of migraine recurrence after multivari-
ate analysis in the present study. In the literature search, this 
variable was not evaluated as a possible risk factor. However, 
most of the articles were originated from samples of women 
of high socioeconomic level7,8.
The present study had the limitation of a retrospective re-
cruitment. However, its prospective part with a follow-up in 
the fourth week after delivery, in both MO and MA sufferers, 
showed a group mostly formed by poor, black/colored wom-
en, with only regular schooling, reflecting the population as-
sisted by IMIP, a charity hospital in Recife, Brazil. These char-
acteristics are added to the study of Sances et al.7, which 
showed similar results, studying only MO patients, in regards 
to breastfeeding being a protective factor for migraine recur-
rence in the first and fourth postpartum weeks in a white, 
well-educated, and middle class population. Delay in the re-
turn of migraine attacks is not only reflected in the pain ex-
perienced by migraine sufferers, but it also helps to alleviate 
social, family, and work issues30.
In conclusion, we reiterate a new and important role of 
EBF and the prevention of breastfeeding problems, avoiding 
one of the most important causes of early weaning, the pro-
tective factor associated with the decline in postpartum mi-
graine recurrence among MO and MA sufferers.
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